Health guideline panels struggle with conflicts of interest
When a federal panel recently recommended against prostate cancer screening for most men, it tried to steer clear of any suggestions of commercial bias. All 16 members of the United States Preventive Services Task Force were vetted to ensure they had no financial conflicts that would prohibit them from voting, according to the panel's vice chairman, Dr. Albert L. Siu. But three other federal panels that are quietly developing major public health guidelines on the leading causes of cardiovascular disease — hypertension, cholesterol and obesity — operate under less stringent ethics recommendations. And one potential conflict after another has surfaced among the members, with some receiving speakers' fees from drug companies, others consulting for pay and others doing company-financed research.
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Why Open Payments Irks Physicians
- Top Provider Billing Mistakes Are Changing
- Difficult Patients: It's Not Them, It's You, Doctor
- Overcoming a Payer Mix 'Nightmare'
- Employee Engagement: Make It Meaningful
- These Algorithms Reduce Readmissions
- Payer Calls for More Primary Care Docs, Team Care